Fukushima Medical University is a public university, located in the city of Fukushima, Japan.

During the past decade, Fukushima Medical University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fukushima Medical University" #1 sponsor was "Chiba University" with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul" with 1 trials sponsored, "Fukushima Medical University" with 1 trials sponsored and "HI-Bio" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fukushima Medical University" #1 collaborator was "Human Genome Center, Institute of Medical Science, University of Tokyo" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Fukushima Medical University" are "Age Related Macular Degeneration" (1 trials), "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials), "Breast Neoplasms" (1 trials), "Demyelinating Diseases" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Fukushima Medical University" in a lesser frequency.

Most popular intervention types in "Fukushima Medical University" are "Drug" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Azacitidine" (1 trials), "Biliary drainage" (1 trials), "Exemestane" (1 trials) and "Felzartamab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fukushima Medical University" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Fukushima Medical University". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fukushima Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fukushima Medical University, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".